ClinicalTrials.gov
ClinicalTrials.gov Menu

Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis (Cancer-DACUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00450645
Recruitment Status : Unknown
Verified March 2009 by Azienda Ospedaliera Universitaria Policlinico.
Recruitment status was:  Recruiting
First Posted : March 22, 2007
Last Update Posted : March 4, 2009
Sponsor:
Information provided by:
Azienda Ospedaliera Universitaria Policlinico